Why Regulatory Affairs Germany support is valuable
Regulatory support may involve pharmaceutical studies under CTIS, standalone medical device clinical investigations, or projects involving drug-device combinations and in vitro diagnostic or companion diagnostic components, depending on the applicable pathway.
German submission requirements can be time-sensitive, document-heavy, and operationally demanding. Practical local support helps improve submission readiness, communication efficiency, and overall coordination across the study team.
Regulatory services
- Submission strategy support
- CTA and related documentation support
- CTIS-related support
- Ethics and authority coordination
- Amendments and notifications
- Submission follow-up and communication
- Review of regulatory documentation
- Compliance-oriented operational support
Regulatory submission coordination
- Competent authority interactions involving BfArM and PEI
- Ethics committee submission support and follow-up communication
- Radiation authority (BfS) coordination where applicable
- BOPST-related documentation where required
- Timelines aligned with EU CTR and local approval dependencies
- Coordination of country-specific document requirements
Operational and regulatory perspective
Because study start-up, submissions, and site activities often overlap, a consultant who understands both operational realities and regulatory requirements can help reduce handover risk and improve continuity.
Support may relate to pharmaceutical studies under CTIS, medical device clinical investigations, combination products, and selected in vitro diagnostic or companion diagnostic projects in Germany.
Need Regulatory Affairs Germany support?
Please send your study type, submission stage, timelines, and countries involved.